Browse by intervention

Probiotics: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve in Issue 01. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

Research issue
Issue 01
Data through
2026-08-09
Evidence map version
v1.1.0

How to read this

Phoenix research is longitudinal and observational: we follow real APOE4 carriers over time and compare each member with their own earlier self, with no placebo group, no randomisation, and members choosing their own interventions.

That means these are strong signals pointing at what to test next, not proof of cause. Most nutrition, supplement and lifestyle research you read online has exactly the same design. The difference is that we say so, and we show you the confounders.

Read the full methods and limits

What the Phoenix community is measuring

Browse exact outcomes and interventions. Each result keeps its source, measurement rule and audit record beside the claim.

Probiotics evidence dossier

Evidence collected through 2026-08-09.

Most promising

Homocysteine

Laboratory homocysteine result · Aim: lower

Probiotics

Positive individual result

One curated Lactobacillus reuteri case lowered homocysteine 9.9%; the paired values were not published.

Selected member cases

  1. Probiotic Repeat · genotype not disclosed · female · age 60-69

    Homocysteine fell 9.9%; the public report does not print the paired values.

    What else changed: no nearby starts were recorded.

    Next study: repeat Homocysteine after a dated Probiotics window.

1 selected member case · not a response rate

Observations
1
Measurements
2
Sources and context

Members with a logged probiotic and repeat homocysteine result; the visible case is curated.

  • report-lines-248-343, reviewed by independent verifier

1 selected case shown with this evidence.

LDL cholesterol

Laboratory LDL cholesterol result · Aim: lower

Probiotics

Repeated positive

Two probiotic strains in two clean curated cases lowered LDL cholesterol by 32.7% and 26.1%.

Selected member cases

  1. Probiotic Repeat · genotype not disclosed · female · age 60-69

    157 → 116 mg/dL · -26.1% · 87 days

    What else changed: no nearby starts were recorded.

    Next study: A human trial supports strain-specific LDL lowering, so Phoenix should record strain and dose rather than pool every probiotic.

  2. Triple Mover · APOE3/4 · female · age 40-49

    98 → 66 mg/dL · -32.7% · 56 days

    What else changed: no nearby starts were recorded.

    Next study: A human trial supports strain-specific LDL lowering, so Phoenix should record strain and dose rather than pool every probiotic.

2 selected member cases · not a response rate

Observations
2
Measurements
4
Sources and context

Members with a logged probiotic and repeat LDL result; the public cases are curated rather than exhaustive.

  • report-lines-248-343, reviewed by independent verifier

2 selected cases shown with this evidence.

Not yet measured

A human trial supports strain-specific LDL lowering, so Phoenix should record strain and dose rather than pool every probiotic.

How to test it

Baseline
Record LDL cholesterol before the dated probiotic start.
Duration
84 days
Adherence
Record strain, dose and adherence throughout the window.
Retest
Repeat LDL cholesterol after 12 weeks.
Falsifier
A predeclared strain-specific cohort does not reproduce lower LDL cholesterol.
Eligible-member target
40 members

Total cholesterol

Laboratory total cholesterol result · Aim: lower

Probiotics

Repeated positive

Two curated probiotic cases lowered total cholesterol; one moved from 199 to 171 mg/dL and the other fell 17.7%.

Selected member cases

  1. Probiotic Repeat · genotype not disclosed · female · age 60-69

    Total cholesterol fell 17.7%; the public report does not print the paired values.

    What else changed: no nearby starts were recorded.

    Next study: repeat Total cholesterol after a dated Probiotics window.

  2. Triple Mover · APOE3/4 · female · age 40-49

    199 → 171 mg/dL · -14.1% · 56 days

    What else changed: no nearby starts were recorded.

    Next study: repeat Total cholesterol after a dated Probiotics window.

2 selected member cases · not a response rate

Observations
2
Measurements
4
Sources and context

Members with a logged probiotic and repeat total cholesterol result; the visible cases are curated.

  • report-lines-248-343, reviewed by independent verifier

2 selected cases shown with this evidence.

Triglycerides

Laboratory triglyceride result · Aim: lower

Probiotics

Positive individual result

One clean curated case lowered triglycerides from 49 to 34 mg/dL in 56 days.

Selected member cases

  1. Triple Mover · APOE3/4 · female · age 40-49

    49 → 34 mg/dL · -30.6% · 56 days

    What else changed: no nearby starts were recorded.

    Next study: repeat Triglycerides after a dated Probiotics window.

1 selected member case · not a response rate

Observations
1
Measurements
2
Sources and context

Members with a logged probiotic and repeat triglyceride result; the visible case is curated.

  • report-lines-248-343, reviewed by independent verifier

1 selected case shown with this evidence.

Keep the map

Take every result into your next experiment.

Get the Issue 01 Evidence Map by email. It groups the same evidence by outcome and by intervention, including what worked, what did not, and what Phoenix wants to test next.

Instant PDF · Issue 02 lands in your inbox the day it publishes · No spam

Turn evidence into your next test

Magnesium and homocysteine is 7 members from an answer.

Forty carriers with a dated start and a repeat blood test close it. Creatine, vitamin D3 and B12 sit further back. Your next blood test is somebody else's answer, and theirs is yours.

Take the 7-minute assessment